Mitochondria as a target for neuroprotection
- Authors: Silachev D.N.1, Zorova L.D.2, Usatikova E.A.1, Pevzner I.B.1, Babenko V.A.3, Gulyaev M.V.4, Pirogov Y.A.5, Antonenko Y.N.1, Plotnikov E.Y.1, Zorov D.B.1
-
Affiliations:
- Belozersky Institute of Physico-Chemical Biology
- International Laser Center
- Faculty of Bioengineering and Bioinformatics
- Faculty of Fundamental Medicine
- Faculty of Physics
- Issue: Vol 10, No 1 (2016)
- Pages: 28-36
- Section: Articles
- URL: https://journals.rcsi.science/1990-7478/article/view/213159
- DOI: https://doi.org/10.1134/S1990747815050128
- ID: 213159
Cite item
Abstract
Despite all the efforts of modern medical and biomedical sciences, the effective therapeutic treatments that would restore the brain functions lost after stroke have not been found yet. At the same time, experimental preclinical studies revealed an arsenal of effectors having potential for clinical applications. Identification of the key signaling pathways, both damaging and protective, can accelerate the development and implementation of new effective neuroprotectors. One of the key elements of these pathways is mitochondrion. In this context, we studied various therapeutic approaches to the treatment and prevention of cerebral ischemia, which are aimed at modulation of mitochondrial functions. The spectrum of tested neuroprotectors included antioxidants, uncouplers of respiration and phosphorylation, as well as ischemic, remote, and pharmacological preconditioning. Their efficacy and therapeutic windows were compared and the possibility of combining different methods in order to maximize their efficiency was considered.
About the authors
D. N. Silachev
Belozersky Institute of Physico-Chemical Biology
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992
L. D. Zorova
International Laser Center
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992
E. A. Usatikova
Belozersky Institute of Physico-Chemical Biology
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992
I. B. Pevzner
Belozersky Institute of Physico-Chemical Biology
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992
V. A. Babenko
Faculty of Bioengineering and Bioinformatics
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992
M. V. Gulyaev
Faculty of Fundamental Medicine
Email: zorov@genebee.msu.su
Russian Federation, Lomonosovsky pr. 31, Moscow, 117192
Y. A. Pirogov
Faculty of Physics
Email: zorov@genebee.msu.su
Russian Federation, Leninskye Gory 1, Moscow, 119992
Y. N. Antonenko
Belozersky Institute of Physico-Chemical Biology
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992
E. Y. Plotnikov
Belozersky Institute of Physico-Chemical Biology
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992
D. B. Zorov
Belozersky Institute of Physico-Chemical Biology
Author for correspondence.
Email: zorov@genebee.msu.su
Russian Federation, Leninskie Gory 1, Moscow, 119992